BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35994937)

  • 1. Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study.
    Marshall AD; Martinello M; Treloar C; Matthews GV
    Int J Drug Policy; 2022 Nov; 109():103828. PubMed ID: 35994937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.
    Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M;
    Lancet HIV; 2024 Feb; 11(2):e106-e116. PubMed ID: 38224708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era.
    Ingiliz P; Wehmeyer MH; Boesecke C; Schulze Zur Wiesch J; Schewe K; Lutz T; Baumgarten A; Simon KG; Hueppe D; Rockstroh JK; Mauss S; Christensen S; ;
    Clin Infect Dis; 2020 Aug; 71(5):1248-1254. PubMed ID: 31562816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression.
    Hosseini-Hooshyar S; Hajarizadeh B; Bajis S; Law M; Janjua NZ; Fierer DS; Chromy D; Rockstroh JK; Martin TCS; Ingiliz P; Hung CC; Dore GJ; Martinello M; Matthews GV
    Lancet HIV; 2022 Jun; 9(6):e414-e427. PubMed ID: 35659336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).
    Mora M; Goodyear T; Marcellin F; Shoveller J; Di Beo V; Calzolaio C; Sogni P; Wittkop L; Zucman D; Poizot-Martin I; Lacombe K; Salmon-Céron D; Knight R; Carrieri P
    J Viral Hepat; 2020 Dec; 27(12):1462-1472. PubMed ID: 32810905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men.
    Adu PA; Rossi C; Binka M; Wong S; Wilton J; Wong J; Butt ZA; Bartlett S; Jeong D; Pearce M; Darvishian M; Yu A; Alvarez M; Velásquez García HA; Krajden M; Janjua NZ
    Liver Int; 2021 Mar; 41(3):482-493. PubMed ID: 33305525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
    Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV;
    Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
    Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
    Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia.
    Schroeder SE; Higgs P; Winter R; Brown G; Pedrana A; Hellard M; Doyle J; Stoové M
    J Int AIDS Soc; 2019 May; 22(5):e25288. PubMed ID: 31111671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study).
    Monin MB; Ingiliz P; Lutz T; Scholten S; Cordes C; Martínez-Rebollar M; Spinner CD; Nelson M; Rausch M; Bhagani S; Peters L; Reiberger T; Mauss S; Rockstroh JK; Boesecke C;
    Clin Infect Dis; 2023 Feb; 76(3):e607-e612. PubMed ID: 36004410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017.
    Castry M; Cousien A; Bellet J; Champenois K; Pialoux G; Yazdanpanah Y; Costagliola D; Grabar S; Deuffic-Burban S;
    Euro Surveill; 2021 Sep; 26(38):. PubMed ID: 34558403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of HCV Reinfection Among HIV-Positive MSM and Its Association With Sexual Risk Behavior: A Longitudinal Analysis.
    Newsum AM; Matser A; Schinkel J; van der Valk M; Brinkman K; van Eeden A; Lauw FN; Rijnders BJA; van de Laar TJW; van de Kerkhof M; Smit C; Boyd A; Arends JE; Prins M;
    Clin Infect Dis; 2021 Aug; 73(3):460-467. PubMed ID: 32459339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
    Garvey LJ; Cooke GS; Smith C; Stingone C; Ghosh I; Dakshina S; Jain L; Waters LJ; Mahungu T; Ferro F; Sood C; Freeman C; Phillips C; Dhairyawan R; Burholt R; Sharp H; Ullah S; Gilleece Y; Brown A; Orkin C; Rodger A; Bhagani S
    Clin Infect Dis; 2021 Jan; 72(2):233-238. PubMed ID: 32211763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C reinfection with protease inhibitor-resistant hepatitis C virus in an HIV-coinfected MSM.
    Yilmaz GR; Boesecke C; Schwarze-Zander C; Rockstroh JK
    Liver Int; 2020 Jan; 40(1):47-50. PubMed ID: 31612570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.
    Berenguer J; Gil-Martin Á; Jarrin I; Montes ML; Domínguez L; Aldámiz-Echevarría T; Téllez MJ; Santos I; Troya J; Losa JE; Serrano R; De Guzmán MT; Calvo MJ; González-García JJ;
    AIDS; 2019 Mar; 33(4):685-689. PubMed ID: 30829744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.
    Young J; Wang S; Lanièce Delaunay C; Cooper CL; Cox J; Gill MJ; Hull M; Walmsley S; Wong A; Klein MB;
    Int J Drug Policy; 2023 Apr; 114():103981. PubMed ID: 36893502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study.
    Braun DL; Hampel B; Ledergerber B; Grube C; Nguyen H; Künzler-Heule P; Shah C; Salazar-Vizcaya L; Conen A; Flepp M; Stöckle M; Béguelin C; Schmid P; Rougemont M; Delaloye J; Bernasconi E; Nicca D; Böni J; Rauch A; Kouyos RD; Günthard HF; Fehr JS
    Clin Infect Dis; 2021 Oct; 73(7):e2194-e2202. PubMed ID: 32761122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.
    Chromy D; Bauer DJM; Simbrunner B; Jachs M; Hartl L; Schwabl P; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Mandorfer M; Gschwantler M; Reiberger T
    J Viral Hepat; 2022 May; 29(5):385-394. PubMed ID: 35274399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.